CAPROCK Group, Inc.

SEC CIK: 0001610769
Latest filing: Jul 27, 2026

SEC filings (opens in a new tab)

RXRX holding history

Recursion Pharmaceuticals, Inc. in every 13F filed by CAPROCK Group, Inc., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

RXRX overview All 13F holders of RXRX Full Q2 2026 holdings

Shares (Q2 2026): 14,861
Value: $54.5K
% of portfolio: <0.1%
Quarters held: 2; Since Q4 2025

Holdings of RXRX by CAPROCK Group, Inc., by quarter
Quarter	Shares	Value	% of portfolio	Share change	Action	All holders
Q2 2026	14,861	$54.5K	<0.1%	+14,861	New	Holders
Q1 2026	0	$0	0.0%	−13,026−100.0%	Sold out	Holders
Q4 2025	13,026	$53.3K	<0.1%	+13,026	New	Holders